Determining the adequate number of internal quality control levels: The example of coagulation factor VIII assay

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 5, 2008, Pages 433-437

  Sobas, Frédéric ^a   Mazliak, Laurent ^b   Bellisario, Audrey ^a   Lefranc, Mathieu ^a   Lienhart, Anne ^a   Nougier, Christophe ^a   Négrier, Claude ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Average run length; Correlations between internal quality controls; Factor VIII; Hotelling; Number of control levels

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ARTICLE; CALCULATION; CONCENTRATION (PARAMETERS); INFORMATION; METHODOLOGY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL;

BLOOD COAGULATION TESTS; FACTOR VIII; HUMANS; REFERENCE STANDARDS;

EID: 67649553800     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32830496b8     Document Type: Article

References (18)

1. Hyltoft Petersen P, Ricos C, Stockl D, Libeer JC, Baadenhuijsen H, Fraser C, Thienpont L. Proposed guidelines for the internal quality control of analytical results in the medical laboratory. Eur J Clin Chem Clin Biochem 1996; 34:383-399.
2. CLSI. C24-A3 Statistical quality control for quantitative measurement procedures: principles and definitions. CLSI; 2006.
3. Preston FE, Kitchen S. Quality control and factor VIII assays. Haemophilia 1998; 4:651-653.
4. Kasper CK, Boylen AL, Ewing JV, Luck JJV, Dietrich SL. Hematologic management of hemophilia A for surgery. JAMA 1985; 253:1279-1283.
5. Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of factor VIII and the risk of recurrent veinous thromboembolism. N Engl J Med 2000; 343:457-462.
6. Kamphuisen PW, Eikenboom JC, Bertina RM. Elevated factor VIII levels and the risk of thrombosis. Arterioscler Thromb Vasc Biol 2001; 21:731-738.
7. White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Factor VIII and factor IX subcommittee definitions in hemophilia recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardisation committee of the international society on thrombosis and haemostasis. Thromb Haemost 2001; 85:560.
8. Preston FE, Kitchen S, Jennings I, Woods TA, Makris M. SSC/ISTH. Classification of hemophilia A: can hemophilia center laboratories achieve the new criteria? Thromb Haemost 2004; 2:271-274.
9. Aronsson T, De Verdier CH, Groth T. Factors influencing the quality of analytical methods. A system analysis, with use of computer simulation. Clin Chem 1974; 20:738-748.
10. Klee GG. Tolerance limits short-term analytical bias and analytical imprecision derived from clinical assay specificity. Clin Chem 1993; 39:1514-1518.
11. Hotelling H. Multivariate quality control - Illustrated by the air testing of sample bombsights. Techniques of statistical analysis. New York: MacGraw-Hill; 1947; pp. 111-184.
12. Marquis P. Multidimensional control of analytical processes. Ann Biol Clin 2002; 60:104-110.
13. Dechert J, Case KE. Multivariate approach to quality control in clinical chemistry. Clin Chem 1998; 44:1959-1963.
14. Marquis P, Masseyeff R. Assesment of internal quality control method : application to multidimensional control. Ann Biol Clin 2002; 60:307-316.
15. Westgard JO, Groth T, Aronsson T, Falk H, De Verdier CH. Performance characteristics of rules for internal quality control: probabilities for false rejection and error detection. Clin Chem 1977; 23:1857-1867.
16. Hardisty RM, Macpherson JC. A one-stage factor VIII (antihemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrag 1962; 7:215-229.
17. CLSI. EP5-A2 Evaluation of precision performance of quantitative measurement methods. CLSI; 2004.
18. Westgard JO. Assuring analytical quality through process planning and quality control. Arch Pathol Lab Med 1992; 116:765-769.